Skip to main content
Robert Collins Jr., MD, Oncology, Dallas, TX

RobertHowardCollinsJr.MD

Oncology Dallas, TX

Professor, Internal Medicine, University of Texas Southwestern Medical Center, Southwestern Medical School

Dr. Collins is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Collins' full profile

Already have an account?

  • Office

    5323 Harry Hines Blvd
    Dallas, TX 75390
    Phone+1 214-645-8600
    Fax+1 214-645-2661

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1987 - 1989
  • Baylor University Medical Center
    Baylor University Medical CenterResidency, Internal Medicine, 1984 - 1987
  • University of Missouri Kansas City School of Medicine
    University of Missouri Kansas City School of MedicineClass of 1984

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1987 - 2024
  • TX State Medical License
    TX State Medical License 1986 - 2024
  • OK State Medical License
    OK State Medical License 1985 - 1986
  • AL State Medical License
    AL State Medical License 1965 - 1965
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • LILRB4 Signalling in Leukaemia Cells Mediates T Cell Suppression and Tumour Infiltration  
    Nam Nguyen, Robert Collins, Hong Zhu, Nisha Unni, Benjamin Chen, Jaehyup Kim, Nature

Abstracts/Posters

  • Precision Medicine Treatment in Older AML: Results of Beat AML Master TrialClinically Relevant Abstract
    Robert H. Collins, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Younger Patients with Newly Diagnosed FLT3-Mutant AML Treated with Crenolanib Plus Chemotherapy Achieve Adequate Free Crenolanib Levels and Durable Remissions
    Robert H. Collins, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

  • Remembering Dr. Eugene P. Frenkel, Who Led Division of Hematology and Oncology for 30 Years at UT Southwestern
    Remembering Dr. Eugene P. Frenkel, Who Led Division of Hematology and Oncology for 30 Years at UT SouthwesternJune 23rd, 2019
  • Researchers Uncover Mutated Genes Involved in Lung Cancer; One Affects Nonsmokers
    Researchers Uncover Mutated Genes Involved in Lung Cancer; One Affects NonsmokersOctober 24th, 2017